Mandev Surgipharma Private Limited
About Mandev Surgipharma Private Limited
Data last updated:
Mandev Surgipharma Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2017PTC106287. Its GSTIN is 29AALCM3210G1ZL (Karnataka).
The company has an authorised share capital of ₹4.9 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ranjeet Kumar Jain and Sanjay Kumar Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fateh Tower No.1 G T Road 1st Cross Cottonpet Road, Bangalore, Karnataka, India – 560053.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.94 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹14.1 Lakh (net margin 0.8%) and EBITDA of ₹29.69 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹1.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFateh Tower No.1 G T Road 1st Cross Cottonpet Road, Bangalore, Karnataka, India – 560053
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Mandev Surgipharma Private Limited
The main business activity of Mandev Surgipharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Mandev Surgipharma Private Limited FY 2025 filings available
Mandev Surgipharma Private Limited reported revenue of ₹16.94 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Mandev Surgipharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 2% growth in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Mandev Surgipharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹29.69 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹14.1 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Mandev Surgipharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mandev Surgipharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Mandev Surgipharma Private Limited
Mandev Surgipharma Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tufte Enterprises Private Limited | ₹17.17 Cr (FY 2024) | •••• | •••• | 6.0% | •••• | Moradabad, Uttar Pradesh, India |
| Nuvigen Life Sciences Private Limited | ₹17.13 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Lailesh Surgical Equipments (OPC) Private Limited | ₹17.08 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Kolkata, West Bengal, India |
| Medit Systems Private Limited | ₹17.04 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Kolkata, West Bengal, India |
| Shri Imaging and X-Ray Films Private Limited | ₹17 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Mandev Surgipharma Private Limited this company | ₹16.94 Cr (FY 2024) | •••• | •••• | 2.0% | •••• | Bangalore, Karnataka, India |
| Starlex Health Services and Products Private Limited | ₹16.89 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Perinthalmanna, Kerala, India |
| Unicorn Medident Pvt Ltd | ₹16.83 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | New Delhi, Delhi, India |
| VG Royal Pharmacy Limited | ₹16.81 Cr (FY 2025) | •••• | •••• | 125.0% | •••• | Mumbai, Maharashtra, India |
| Smartqr Technologies Private Limited | ₹16.77 Cr (FY 2025) | •••• | •••• | 511.0% | •••• | Mumbai, Maharashtra, India |
| Biolitec India Private Limited | ₹16.76 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Bengaluru, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Mandev Surgipharma by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Mandev Surgipharma Private Limited
Mandev Surgipharma Private Limited is audited by ANIL BHANDARI & ASSOCIATES for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANIL BHANDARI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Mandev Surgipharma Private Limited
Mandev Surgipharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ranjeet Kumar Jain | Director | 11 Sep 2017 | 9 Years 1 Months | Current |
| Sanjay Kumar Jain | Director | 11 Sep 2017 | 9 Years 1 Months | Current |
| Rakesh Kumar Jain | Director | 11 Sep 2017 | 9 Years 1 Months | Current |
Ownership and Shareholding of Mandev Surgipharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Mandev Surgipharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2018 | Others | ₹1.95 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Mandev Surgipharma Private Limited
Mandev Surgipharma Private Limited has a workforce of 0 employees as of Apr 02, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mandev Surgipharma Private Limited
Mandev Surgipharma Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Fathe Chand ceased to be Director on 29 Aug 2020.
Credit Ratings, Litigation & Regulatory Alerts for Mandev Surgipharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mandev Surgipharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mandev Surgipharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mandev Surgipharma Private Limited
Mandev Surgipharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AALCM3210G1ZL | Karnataka | Active | 15 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mandev Surgipharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mandev Surgipharma Private Limited
Mandev Surgipharma is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 September 2017 (9+ years old) and is registered under CIN U74999KA2017PTC106287.
Mandev Surgipharma reported revenue of ₹16.94 Cr for FY 2024 (up 2% YoY).
Mandev Surgipharma has 3 current directors:
- Ranjeet Kumar Jain - Director
- Sanjay Kumar Jain - Director
- Rakesh Kumar Jain - Director
Mandev Surgipharma reported a net profit of ₹14.1 Lakh (net margin 0.8%) and EBITDA of ₹29.69 Lakh (EBITDA margin 1.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Mandev Surgipharma is -2% over three years and 2% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Mandev Surgipharma is 29AALCM3210G1ZL, registered in Karnataka.
The CIN (Corporate Identification Number) of Mandev Surgipharma is U74999KA2017PTC106287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mandev Surgipharma was incorporated on 11 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Mandev Surgipharma by revenue are Tufte Enterprises Private Limited, Nuvigen Life Sciences Private Limited, Lailesh Surgical Equipments (OPC) Private Limited, Medit Systems Private Limited, Shri Imaging and X-Ray Films Private Limited and 5 more, all in the Healthcare industry (Healthcare Equipment Retail and Distribution).
Fathe Chand ceased to be Director on 29 Aug 2020. Rakesh Kumar Jain was appointed as Director on 11 Sep 2017. Ranjeet Kumar Jain was appointed as Director on 11 Sep 2017. Mandev Surgipharma has 4 board changes on record in total.
The registered office of Mandev Surgipharma is at Fateh Tower No.1 G T Road 1st Cross Cottonpet Road, Bangalore, Karnataka, India – 560053.